Temozolomide
Products billed under this code include Temozolomide.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J8700
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Temozolomide | Accord Healthcare Inc | 16729-0048-53 | 5 | $1.04 |
| Temozolomide | Accord Healthcare Inc | 16729-0048-54 | 14 | $2.912 |
| Temozolomide | Accord Healthcare Inc | 16729-0049-53 | 20 | $4.16 |
| Temozolomide | Accord Healthcare Inc | 16729-0049-54 | 56 | $11.648 |
| Temozolomide | Accord Healthcare Inc | 16729-0050-53 | 100 | $20.80 |
| Temozolomide | Accord Healthcare Inc | 16729-0050-54 | 280 | $58.24 |
| Temozolomide | Accord Healthcare Inc | 16729-0051-53 | 250 | $52.00 |
| Temozolomide | Accord Healthcare Inc | 16729-0129-53 | 140 | $29.12 |
| Temozolomide | Accord Healthcare Inc | 16729-0129-54 | 392 | $81.536 |
| Temozolomide | Accord Healthcare Inc | 16729-0130-53 | 180 | $37.44 |
Show all 35 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Temozolomide | Accord Healthcare Inc | 16729-0130-54 | 504 | $104.832 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0890-72 | 15 | $3.12 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0890-74 | 5 | $1.04 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0891-72 | 60 | $12.48 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0891-74 | 20 | $4.16 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0892-72 | 300 | $62.40 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0892-74 | 100 | $20.80 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0893-74 | 250 | $52.00 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0929-72 | 420 | $87.36 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0929-74 | 140 | $29.12 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0930-72 | 540 | $112.32 |
| Temozolomide | Sun Pharmaceutical Global FZE. | 47335-0930-74 | 180 | $37.44 |
| Temozolomide | AvPAK | 50268-0761-12 | 80 | $16.64 |
| Temozolomide | AvPAK | 50268-0762-12 | 400 | $83.20 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0801-14 | 14 | $2.912 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0801-51 | 5 | $1.04 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0802-14 | 56 | $11.648 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0802-51 | 20 | $4.16 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0803-14 | 280 | $58.24 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0803-51 | 100 | $20.80 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0804-14 | 392 | $81.536 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0804-51 | 140 | $29.12 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0805-14 | 504 | $104.832 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0805-51 | 180 | $37.44 |
| Temozolomide | Amneal Pharmaceuticals, LLC | 65162-0806-51 | 250 | $52.00 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.208 | −$0.217 | 5 MG | Temozolomide | v1, posted September 17, 2026 |
| 3Q26 | $0.425 | +$0.03 | 5 MG | Temozolomide | v1, posted September 15, 2026 |
| 2Q26 | $0.395 | −$0.147 | 5 MG | Temozolomide | v1, posted September 15, 2026 |
| 1Q26 | $0.542 | +$0.087 | 5 MG | Temozolomide | v1, posted September 15, 2026 |
| 4Q25 | $0.455 | +$0.094 | 5 MG | Temozolomide | v1, posted September 8, 2026 |
| 3Q25 | $0.361 | −$0.023 | 5 MG | Temozolomide | v1, posted March 10, 2026 |
| 2Q25 | $0.384 | +$0.119 | 5 MG | Temozolomide | v1, posted March 10, 2026 |
| 1Q25 | $0.265 | $0.00 | 5 MG | Temozolomide | v1, posted December 19, 2025 |
| 4Q24 | $0.265 | +$0.032 | 5 MG | Temozolomide | v1, posted June 11, 2025 |
| 3Q24 | $0.233 | +$0.046 | 5 MG | Temozolomide | v1, posted June 11, 2025 |
| 2Q24 | $0.187 | −$0.094 | 5 MG | Temozolomide | v1, posted March 11, 2025 |
| 1Q24 | $0.281 | +$0.094 | 5 MG | Temozolomide | v1, posted December 19, 2024 |
| 4Q23 | $0.187 | −$0.002 | 5 MG | Temozolomide | v1, posted October 10, 2024 |
| 3Q23 | $0.189 | −$0.012 | 5 MG | Temozolomide | v1, posted June 5, 2024 |
| 2Q23 | $0.201 | −$0.01 | 5 MG | Temozolomide | v1, posted February 23, 2024 |
| 1Q23 | $0.211 | −$0.068 | 5 MG | Temozolomide | v1, posted December 6, 2023 |
| 4Q22 | $0.279 | +$0.024 | 5 MG | Temozolomide | v1, posted June 22, 2023 |
| 3Q22 | $0.255 | −$0.05 | 5 MG | Temozolomide | v1, posted June 9, 2023 |
| 2Q22 | $0.305 | −$0.048 | 5 MG | Temozolomide | v1, posted December 14, 2022 |
| 1Q22 | $0.353 | −$0.005 | 5 MG | Temozolomide | v1, posted June 8, 2022 |
| 4Q21 | $0.358 | −$0.094 | 5 MG | Temozolomide | v1, posted June 2, 2022 |
| 3Q21 | $0.452 | +$0.008 | 5 MG | Temozolomide | v1, posted June 2, 2022 |
| 2Q21 | $0.444 | −$0.088 | 5 MG | Temozolomide | v1, posted March 1, 2022 |
| 1Q21 | $0.532 | – | 5 MG | Temozolomide | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021